Bacteremia
📧 Sign up to get email alerts when something new happens for Bacteremia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-05-05FDA Approved: DAPTOMYCIN — Supplemental Application (Civica, Inc.)
The FDA approved a supplemental application for Civica, Inc.'s daptomycin. This action approves an update requested in the supplemental subm…
-
FDA approval · 2021-04-21FDA Approved: DAPTOMYCIN — Original Application (Hisun Pharmaceuticals USA, Inc.)
FDA approved the original application for daptomycin (generic) by Hisun Pharmaceuticals USA, Inc. for the approved indications of complicate…
-
CLINICAL_TRIALS trial_result · 2021-03-30Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029) [Phase 2]
Phase 2 trial assessing safety, efficacy, and pharmacokinetics of daptomycin (MK-3009) in Japanese pediatric patients with complicated skin …
-
FDA approval · 2020-09-09FDA Approved: DAPTOMYCIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for daptomycin (Hikma Pharmaceuticals USA Inc.), covering an additional formulation/strength under a…
-
FDA approval · 2020-08-31FDA Approved: DAPTOMYCIN — Original Application (Dr. Reddy's Laboratories Inc.,)
FDA approved the original application for daptomycin by Dr. Reddy's Laboratories Inc., marking the first generic approval for the drug. The …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-02-17Clinical Trial Update: A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial [Phase 3]
Phase 3 trial evaluating telavancin for Staphylococcus aureus bacteremia was terminated; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-12-27Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating the safety and efficacy of telavancin for Gram-positive bloodstream infections in cancer patients has co…
-
CLINICAL_TRIALS trial_result · 2019-12-23Clinical Trial Update: Home Away From Home - Medical Outcomes
Completed clinical trial update for a study involving acute myeloid leukemia and neutropenia with mention of bacteremia results.
-
CLINICAL_TRIALS withdrawal · 2019-10-09Clinical Trial Update: Randomized-controlled Trial (RCT) on Combination Antibiotic for Infections Caused by Gram-negative Bacteria [Phase 2, Phase 3]
A randomized-controlled trial evaluating a combination antibiotic for gram-negative infections (bacteremia and healthcare-associated pneumon…
-
FDA approval · 2019-10-03FDA Approved: DAPTOMYCIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for daptomycin from Hikma Pharmaceuticals USA Inc. under ANDA206005. This represents a supplemen…
-
FDA approval · 2019-09-18FDA Approved: DAPTOMYCIN — Supplemental Application (Civica, Inc.)
FDA approved a supplemental application for Daptomycin from Civica, Inc., approving an update to its labeling or indication.
-
CLINICAL_TRIALS trial_result · 2019-08-12Clinical Trial Update: Safety Evaluation of Seraph® 100 to Reduce Bacteremia in Patients on Hemodialysis [NA]
Clinical trial update reporting safety evaluation of Seraph® 100 for reducing bacteremia in patients on hemodialysis; completed with results…
-
FDA approval · 2019-07-12FDA Approved: DAPTOMYCIN — Original Application (Accord Healthcare, Inc.)
FDA approved Accord Healthcare, Inc.'s original application for daptomycin (generic), authorizing a generic version of the antibiotic.
-
FDA approval · 2019-06-26FDA Approved: DAPTOMYCIN — Original Application (BE Pharmaceuticals Inc.)
FDA approved BE Pharmaceuticals Inc.'s original application for daptomycin, enabling the generic version of this antibiotic.
-
FDA approval · 2019-06-24FDA Approved: DAPTOMYCIN — Original Application (Accord Healthcare Inc.)
FDA approves the original application for Daptomycin (generic) from Accord Healthcare Inc., authorizing its commercialization as a generic a…
-
FDA approval · 2019-06-12FDA Approved: VANCOMYCIN HYDROCHLORIDE — Original Application (Slate Run Pharmaceuticals, LLC)
FDA approved the vancomycin hydrochloride original application for Slate Run Pharmaceuticals, enabling a generic version of this antibiotic.
-
FDA approval · 2019-02-15FDA Approved: TYZAVAN — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved TYZAVAN (vancomycin) from Hikma Pharmaceuticals USA Inc. under an Original Application (NDA211962). This marks the brand’s offi…
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults [Phase 3]
Phase 3 trial comparing Vabomere to best available therapy in adults with serious infections; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-09-10Clinical Trial Update: Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective Endocarditis [Phase 2]
Phase 2 trial evaluating dalbavancin versus standard of care for completion of treatment in complicated bacteremia or infective endocarditis…
-
CLINICAL_TRIALS research · 2018-07-06Clinical Trial Update: Prevalence and Characterization of Diagnostic Error Among Patients With Bacteremia
A completed clinical trial update assessing the prevalence of diagnostic errors among patients with bacteremia and characterizing the error …
-
CLINICAL_TRIALS trial_result · 2018-06-14Clinical Trial Update: Piperacillin/Tazobactam for Bacteremia With Organisms Producing Chromosomally-Encoded AmpC Beta-Lactamase
A completed clinical trial evaluating piperacillin/tazobactam for bacteremia caused by organisms producing chromosomally encoded AmpC beta-l…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Clinical Impact of Fluoroquinolone Resistance in Bacteremia Caused by Gram-Negative Bacilli of Urinary Tract Origin
Completed clinical trial evaluating how resistance to fluoroquinolones affects outcomes in bacteremia due to Gram-negative bacilli originati…
-
FDA approval · 2018-06-05FDA Approved: DAPTOMYCIN — Original Application (Mylan Institutional LLC)
FDA approved a generic daptomycin product from Mylan Institutional LLC via an Original Application. This approval provides a non-brand versi…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Diagnosis of Bacteremia/Septicemia and Culture Negative Endocarditis by the Karius Sequencing-Based Infectious Disease Diagnostic Assay
The clinical trial update reports completion of a study evaluating the Karius sequencing-based infectious disease diagnostic assay for diagn…
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae
Completed clinical trial investigating cases of serious infections due to carbapenem-resistant Enterobacteriaceae across multiple infection …